Clinical Trials Logo

Clinical Trial Summary

The nodal involvement in squamous cell carcinomas of the upper aerodigestive tract (VADS) is one of the main factors of poor prognosis, justifying the surgical management of neck dissection as a reference treatment.

Under the influence of the American Hayes Martin, it was considered until the 1960s that "over the intervention was, the greater the chance of recovery was". But has since been developed by the Argentine Osvaldo Suarez the concept of functional course, which consists of resection of lymph node tissue while retaining the main structures (muscles, nerves, vessels), as opposed to the recess radical which is reserved for the invasive metastasis.

In addition to these notions, our job is to evaluate the quality of life of patients with SCCHN, N0 clinical and radiological, enjoying a functional neck dissection including IIb sector to support the approach which would be to stop the systematic inclusion of this territory.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02878655
Study type Observational
Source University Hospital, Caen
Contact Roger VIVIEN, MD
Email babin-e@chu-caen.fr
Status Recruiting
Phase
Start date February 2015
Completion date December 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04595981 - Chemo-embolization for Head and Neck Cancer Phase 2
Enrolling by invitation NCT01393184 - Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN Phase 2
Completed NCT04107103 - Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma Phase 2
Recruiting NCT04925284 - Study of XB002 in Subjects With Solid Tumors (JEWEL-101) Phase 1
Recruiting NCT03771820 - Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen Phase 2
Completed NCT02573259 - A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors Phase 1